Ricevi le ultime notizie sulle azioni Sana Biotechnology con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di SANA

Ultime notizie per

Sana Biotechnology

Sana Biotechnology Inc

Sanara MedTech Inc

SANAI HEALTH IND GROUP CO by SANAI HEALTH IND GROUP CO LTD.

Sanarco Funds Inc

Sanatana Resources Inc

Arbutus Biopharma Corporation - Common Stock

Arbutus Biopharma

AnaptysBio

ArriVent BioPharma

BridgeBio Oncology Therapeutics, Inc. - Common Stock

BridgeBio Oncology

Biohaven

CareDx

Day One Biopharmaceuticals, Inc. - Common Stock

Day One Biopharmaceutical

Monte Rosa Therapeutics, Inc. - Common Stock

Monte Rosa Therapeutics

Inhibrx Biosciences

Iovance Biotherapeutics, Inc. - Common Stock

Iovance Biotherapeutics

Kodiak Sciences

Kura Oncology

MoonLake Immunotherapeutics - Class A Ordinary Shares

MoonLake

Nanobiotix

Anbio Biotechnology - Class A Ordinary Shares

Anbio Biotechnology

Intellia Therapeutics, Inc. - Common Stock

Intellia Therapeutics

Organogenesis Holdings

Palvella Therapeutics, Inc. - Common Stock

Palvella Therapeutics

Rezolute

ARS Pharmaceuticals

Savara

Tango Therapeutics

Tyra Biosciences

Valneva

Xencor

Sana Biotechnology (SANA) Previsione

Notizie

Utili

Quote.Nav.option-chain

Valutazioni degli analisti

Insider trading

Vendite allo scoperto

Rapporto azionario

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.

Comments

Sana Biotechnology Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO